Recently, several studies reported that miR-301b-3p targets different ligands to mediate BC proliferation, migration and invasion (Fan et al., 2021; Lu et al., 2021; Liu et al., 2021), and that TGFBR2 could both inhibit and promote the growth of BC cells. Here, TGFBR2 is linked to breast cancer.